...Chang Hong; Han-Zhi Dong; Rui-Ning Li; Hong-Bo Zhu; Qi-Mei Li; Hao Cui; Cheng-Yi Hu; Chao-Yi Huang; Jie Peng; Li Liu; Xue-Jing Zou; Lu-Shan Xiao Background: Immune checkpoint inhibitors (ICIs) have improved survival outcomes and resulted in long-term responses in primary liver cancer in some...

...Miodrag N. Krstić; Dragana Mijač; Ratko S. Tomašević; Snežana Lukić; Milica Stojković Lalošević; Jovan M. Krstić; Tomica Milosavljević Background: Available data suggest that the prevalence of chronic liver disease (CLD) and primary liver cancer is rising in Europe and represents a major public...

...Peter Robert Galle Hepatocellular carcinoma (HCC) is the third most common cause of cancer-related deaths worldwide. HCC represents more than 90% of primary liver cancers. There is a growing incidence of HCC worldwide. In the Western world, HCC arises in a cirrhotic background in up to 90% of cases...

...) treatment, enabling a ‘common language' to be used in daily clinical practice and for the nationwide follow-up survey. The Japanese General Rules for the Clinical and Pathological Study of Primary Liver Cancer, which provide detailed descriptions of HCC, are excellent and are unique to Japan. Items...